InvestorsHub on MSN
Nektar gains after durable efficacy shown in atopic dermatitis study
Shares of Nektar Therapeutics (NASDAQ:NKTR) moved higher on Tuesday after the company released encouraging long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results